Childhood acute lymphoblastic leukemia
Other Names for this Disease
- Childhood acute lymphocytic leukemia
- Pediatric acute lymphoblastic leukemia
- Childhood ALL
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
lymphoblasts, B lymphocytes, or T lymphocytes. These cells do not function normally and have trouble fighting off infections. Signs and symptoms may include fever; easy bruising or bleeding; bone or joint pain; painless lumps in the neck, underarm, stomach, or groin; weakness; fatigue; and/or loss of appetite. Treatment depends on several factors and may include combination chemotherapy, targeted therapy, and/or stem cell transplant.Childhood acute lymphoblastic leukemia (ALL) is a type of cancer of the blood and bone marrow, and the most common type of cancer in children. In children with this condition, too many stem cells made by the bone marrow become
Last updated: 4/20/2015
- General Information About Childhood Acute Lymphoblastic Leukemia. National Cancer Institute. April 13, 2015; http://www.cancer.gov/cancertopics/pdq/treatment/childALL/Patient/page1.
- Cancer.net provides oncologist-approved cancer information from the American Society of Clinical Oncology and has information about Childhood acute lymphoblastic leukemia.
- The Mayo Clinic Web site provides further information on Childhood acute lymphoblastic leukemia.
- MedlinePlus was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.
- The Merck Manual provides information on this condition for patients and caregivers.
- The National Cancer Institute provides the most current information on cancer for patients, health professionals, and the general public.
- Medscape Reference provides information on this topic. You may need to register to view the medical textbook, but registration is free.
- The Monarch Initiative brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch’s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.
- Orphanet is a European reference portal for information on rare diseases and orphan drugs. Access to this database is free of charge.